The bromocresol purple methods for the determination of serum albumin on the Du Pont aca and on the KONE CD show very acceptable linear r nges and imprecision data. Comparison of methods showed good agreement between albumin determinations on the two Instruments.
A new dye binding technique for the determination of albumin in serum, using bromocresol purple, was introduced by Loudefb ck et al. (1) . Automatisation was described by Pinnell & Northam (2) for a contino s flow system, aijd its performance was compared with that of an established bromocresol green method. Hayth rn & Sheehan (3) incre sed the bromocresol purple concentration of 40 μιηοΐ/ΐ used by Pinnell & Northam to 80 μτηοΐ/ΐ to obtain better linearity. Duggan & Duggan (4) concluded that bromocresol purple has importarit advantages over bromocresol green in measiaring albumin, namely improved specificity and higher reaction velocity. We have evaluated a new albumin method based on the bromocresol' purple reaction for the Du Pont aca. We present the results of this evaluation and a comparison of the aca method with a similar procedure on the KONE CD.
Materials and Methods
Instruments aca II (E.I. Du Pont de Nemours and Co., Wilmington, DE 19898, USA) KONE CD (KONE OY, SF-0232 Espoo, Finland). The KONE C was instructed by program version 6.22.
680
Harff: Albumin determination with bromocresol purple man scrum), from General Diagnostics, USA. The Laurell rocket technique, with albumin Standard product No. 0RDT 02 purchased from Behringwerke AG, Marburg, FRG, was used to assay the albumin content of the Automated Lock-in calibration serum. Fresh patients' sera from our hospital were used in the method comparison.
Procedure
All specimens to be analysed on the KONE CD were prediluted 10+1 with physiological NaCl with the automatic dispenser KONE D. Diluted specimen (25 μΐ) and bromocresol purple reagent (475 μΐ) were added to a 24 'KONE' cuvette block. Calibration was performed with two samples of Automated Lock-in. After dispensing and mixing in a 24 cuvette block, the cuvette block was meas red immediately on the colorimeter KONE C at 600 nm. For very lipaemic sera a serum blank was subtracted. No interference was caused by bilirubin in concentrations up to 250 μΓηοΙ/1 measured without a serum blank.
On the aca II a bichromatic (600 nm -540 nm) measurement is performed to minimize the interference from lipaemia. Bilirubin interfered at concentrations above 350 μπηοΙΛ Α filter balance was performed every day.
Protein electrophoresis was performed on cellulose acetate menv branes, with Ponceau-S staining.
Results and Biscussion

Linearity
To obtain specimens with increased albumin concentrations for the linearity study, human sera were frozen, and ice was removed during thawing. With these specimens, a linear analytical r nge between 0 g/l and at least 80 g/1 was obtained for the KONE CD and the aca II.
Imprecision
Table l presents the data on within nm imprecision for both bromocresol purple methods, calculated from duplicates of patients' samples. Both duplicates were analysed in the same run. Depending on the concentration r nge, the data were classified into three groups. Tp determine the imprecision between days, three control sera were analysed by the KONE CD and aca II on each of 22 consecutive days. Results are shown in table 2. Again, the coefficient of Variation appears to be similar for both methods and rather independent of the albumin concentration, The precision clearly suffices for clihical needs. Quality control: Materials and programs To test the suitability of different quality control products, we determined the lbiimin concentration in 9 quality control sera in 4-fold nalyses with both methods. As can be seen from When comparing the reference values for the bromocresol green method with the results with the bromocresol purple method, all human control sera show acceptable agreement, except MONI-TROL I E. The albumin concentration in the quality control products was also determined by protein electrophoresis and immunochemically with rate nephelometry. For MONI-TROL I E, protein electrophoresis gave a value of 46.3 g/l, whereas rate nephelometry gave 34.5 g/l. Thus, MONI-TROL I E probably contains non-human albumin, causing a discrepancy between the results obtained with the two bromocresol purple methods and the reference value for the bromocresol green method. As a consequence, only human based quality control sera can be recommended for the bromocresol purple method, and a separate reference value for this method is required.
Difficulties similar to the above are encountered in external quality control programs. Thus, with the bromocresol purple method we were not able to participate in the Wellcome, the National Dutch or the regional Amsterdam quality control program. An improvement is expected from the introduction of human based control sera into the regional Amsterdam quality control program. The quality control program from Ortho Diagnostics is in principle s itable for the bromocresol purple method. At present only one other participant uses the bromocresol purple method. We have used the method routinely since January 1981 for serum albumin determination pn the KONE CD.
The quality control data of Ortho control sera, using one analysis at each level each day, were used to calculate the mean and Standard deviation per month (from January 1981 until December 1981 Ortho Normal and Ortho Abnormal were used; from December 1981 Ortho Level I and Ortho Level II were used). The means per month of Ortho Normal varied between 41.70 g/l and 42.21 g/l; Ortho Abnormal between 36.49 g/l and 36.86 g/1; Ortho Level I between 26.98 g/l and 27.66 g/l; Ortho Level II between 39.08 g/l and 39.83 g/l. The possible signifiU cance of differences between the given extreme vaiues of means was examined by Studenfs t test; Ortho Normal: t = 1.79, ΟΛ>Ρ>0.05; Ortho Abnormal: t = 1.34, 0.5>P>0.1; Ortho Level I: t = 2.81, 0.01>P>0.001; Ortho Level H: t = 3.61, 0.01>P>0.001. During the period that Ortho Normal and Ortho Abnormal were used, the degree of probability is larger than the conventional level of 5%. The null hypothesis that there is no significant difference between the means is therefore somewhat likely. However, during the period that Ortho Level I and Ortho Level II were used the degree of probability is srnaller than the conventional level of 5%, so it is likely there is a significant difference between the means. It appeared that on March 9 of 1982 a new lot of bromocresol purple reagent was introduced, which caused a decrease of the level of the two controls! Excluding the three month period before the change the reagent lot, the means per month period of Ortho Level I varied between 26.98 g/l and 27.39 g/l; Ortho Level II between 39.08 g/l and 39.53 g/l; Ortho Level I: t = 1.67, 0.5>P>0.1; Ortho Level II: t = 2.38, 0.05>P>0.02. New photometer lamps and a change of the filter wheel had no detectable influence on the results.
The Standard deviations (calculated for each monthly period) of Ortho Normal varied between 0.7 g/l and 0.9* g/l; Ortho Abnormal between 0.5 g/l and 0.8 g/l; Ortho Level I between 0.4 g/l and 0.7 g/l; . Ortho Level II between 0.5 g/l and 0.8 g/l.
Except for the deviation of the monthly mean caused by a change of the lot No. of reagent, it can be concluded that the performance of the bromocresol purple method on the KONE CD over a two year period is acceptable.
Comparison of methods
Methods were compared according to the guidelines proposed by the American National Committee for Clinical Laboratory Standards (NCCLS, draft document PSEP 4 (5)). These guidelines are the basis for making a claim about inaccuracy. It prescribes that at least 100 fresh patients' samples should be analysed in duplicate by both the test method and the comparative analytical method. The experiment must cover a period of at least four days, which permits a maximum of 25 samples to be analysed in one day, or it can extend over a longer period of time if that is convenient for the evaluation study.
Over 20 days, 100 fresh patients' samples were analysed in duplicate on the aca II, the KONE CD and by protein electrophoresis. The results were analysed statistically with the NCCLS accuracy FOR-TRAN Computer program.
The regressjon analysis between albumin obtained by protein electrophoresis (x-axis) and the bromo- cresol purple aca II method (y-axis), ( fig. 1 ), resulted in a slope of 0.995 (95% confidence ränge: 0.964 to 1.025) and an intercept of -1.048 g/l (95% confidence ränge: -2.17 g to 0.08 g/l). Thus, a statistical difference between the methods was not observed. The Standard error of estimate, S yx , is 1.55 g/l. From the scatterplot of the residuals from the regression line it was concluded that the variance about the line does not change with concentration. With a second degree polynomial fit and appropiate F test, comparison of data from the two modifications was found to be linear (F = 1.74, not significant). The same patients' samples used for the fegression analysis between protein electrophoresis and the bromocresol purple method on aca II, were at the same time also analysed on the KONE CD.
The regression analysis between the bromocresol purple method on the KONE CD (x-axis) and aca II (y-äxis) showed a close correlation to each other ( fig.  2) . With a slope of 0.980 (95% confidence fange: 0.959 to 1.002) and an intercept of -0.349 g/l (95% confidence ränge: -1.158 g/l to 0.460 g/ ) a statistically significant difference between the methods could not be observed. The Standard error of estimate, S yk , is 1.18 g/l. From the scatterplot of the residuals from the regression line it was concluded that the variance about the line does not change with concentration. With a second polynomial fit and appropiate F test, comparison of data from the two mödifications was found to be linear (F = 4.82, not significant).
